ErikRDubberkeMD
Infectious Disease • Saint Louis, MOAssistant Professor, Internal Medicine, Washington University School of Medicine
Dr. Dubberke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
620 S Taylor Ave
# Dv
Saint Louis, MO 63110Phone+1 314-362-9098Fax+1 314-362-9851
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Infectious Disease, 2002 - 2004- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1999 - 2002
University of Illinois College of MedicineClass of 1999
Certifications & Licensure
MO State Medical License 2000 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Autologous Fecal Therapy Start of enrollment: 2014 Mar 01
- Fecal Microbiota Transplantation (FMT) for MDRO UTI Start of enrollment: 2018 Feb 08
- TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment Start of enrollment: 2017 Dec 29
- Join now to see all
Publications & Presentations
PubMed
- 414 citationsClinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society f...L Clifford McDonald, Dale N Gerding, Stuart Johnson, Johan S Bakken, Karen C Carroll
Clinical Infectious Diseases. 2018-03-19 - 120 citationsEpidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approachKamal Desai, Swati B. Gupta, Erik R. Dubberke, Vimalanand S. Prabhu, Chantelle Browne
BMC Infectious Diseases. 2016-06-18 - 54 citationsMetabolomic networks connect host-microbiome processes to human Clostridioides difficile infectionsJohn I. Robinson, William Weir, Jan R. Crowley, Tiffany Hink, Kimberly A. Reske
The Journal of Clinical Investigation. 2019-09-03
Press Mentions
Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (Ribaxamase) in Allogeneic Hematopoietic Cell Transplant RecipientsApril 13th, 2023
Synthetic Biologics Reports Second Quarter 2019 Operational Highlights and Financial ResultsNovember 4th, 2019
Gut Makeup Could Make Diarrhea Less LikelyAugust 16th, 2019- Join now to see all
Grant Support
- C. Difficile Disease In Stem Cell Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2009–2011
- Validation And Modeling Of A C. Difficile Infection Risk Prediction IndexNational Institute Of Nursing Research2009–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
